Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 46Lung Neoplasms 29Neoplasms 26Colorectal Neoplasms 21Prostatic Neoplasms 16Uterine Cervical Neoplasms 9Fatigue 9Hematologic Neoplasms 8Lymphoma 7Hematopoietic and Lymphatic System Neoplasm 7Anxiety Disorders 7Papillomavirus Infections 6Melanoma 6Neoplasm Metastasis 5Multiple Myeloma 5Gastrointestinal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Skin Neoplasms 4Ovarian Neoplasms 4Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4Depression 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Arthritis, Reactive × Educational Status × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡